129 related articles for article (PubMed ID: 32788941)
1. Upregulation of ECT2 is associated with transcriptional program of cancer stem cells and predicts poor clinical outcome in gastric cancer.
Gong DY; Chen X; Yang TL; Wang Y; Guo Y; Zeng JH; Chen SZ
Oncol Lett; 2020 Oct; 20(4):54. PubMed ID: 32788941
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.
Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y
Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.
Guo Z; Chen X; Du T; Zhu D; Lai Y; Dong W; Wu W; Lin C; Liu L; Huang H
Med Oncol; 2017 Jan; 34(1):13. PubMed ID: 28012134
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic significance of ECT2 in invasive breast cancer.
Wang HK; Liang JF; Zheng HX; Xiao H
J Clin Pathol; 2018 May; 71(5):442-445. PubMed ID: 29051317
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential biomarkers and their clinical significance in gastric cancer using bioinformatics analysis methods.
Liu J; Zhou M; Ouyang Y; Du L; Xu L; Li H
PeerJ; 2020; 8():e9174. PubMed ID: 33062405
[TBL] [Abstract][Full Text] [Related]
6. Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA.
Bai X; Yi M; Xia X; Yu S; Zheng X; Wu K
Cancer Manag Res; 2018; 10():4039-4050. PubMed ID: 30319288
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis.
Li Y; Cai X; Chen B; Gu H; Liu C
Exp Ther Med; 2017 Nov; 14(5):4862-4868. PubMed ID: 29109759
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients.
Zhang H; Geng Y; Sun C; Yu J
J Oncol; 2021; 2021():2102890. PubMed ID: 34367280
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma.
Zhu L; Qin G; Ye L; Jiang LZ; Zhou TJ; Luo B; Wen TY; Liu YL; Chen HY
Oncol Lett; 2019 Jun; 17(6):5699-5704. PubMed ID: 31186795
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.
Yi M; Zhang D; Song B; Zhao B; Niu M; Wu Y; Dai Z; Wu K
Exp Hematol Oncol; 2022 Dec; 11(1):107. PubMed ID: 36572949
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
[TBL] [Abstract][Full Text] [Related]
13. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.
Wang HB; Yan HC; Liu Y
Clin Transl Oncol; 2016 Jul; 18(7):735-42. PubMed ID: 26497353
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer.
Xiu Y; Liu W; Wang T; Liu Y; Ha M
Mol Clin Oncol; 2019 May; 10(5):497-505. PubMed ID: 30967944
[TBL] [Abstract][Full Text] [Related]
16. ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Wang J; Yang S; Min L; Zhu S; Guo S; Zhang S
Front Oncol; 2020; 10():589241. PubMed ID: 33634019
[TBL] [Abstract][Full Text] [Related]
17. Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy.
Soltan MA; Eldeen MA; Sajer BH; Abdelhameed RFA; Al-Salmi FA; Fayad E; Jafri I; Ahmed HEM; Eid RA; Hassan HM; Al-Shraim M; Negm A; Noreldin AE; Darwish KM
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106813
[TBL] [Abstract][Full Text] [Related]
18. Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.
Chen Z; Liu J; Zhang Y
Med Sci Monit; 2017 Aug; 23():3861-3868. PubMed ID: 28794404
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of epithelial cell transforming sequence 2 expression in cancers: a systematic review and meta-analysis.
Li B; Lin JP; Li Z; Yin C; Yang JB; Meng YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4139-4148. PubMed ID: 31698961
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
Tian X; Wang N
Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
